← Read
Testosterone and Age: What Every Man Should Know
Body & Health
8 min read
Total testosterone tells only part of the story. Free testosterone and the symptoms matter more.
← Read
The marketing around testosterone has done an effective job of convincing men that any sign of ageing - fatigue, reduced drive, a softening physique - is likely the result of low testosterone and treatable with supplementation. The reality is considerably more nuanced. Testosterone does decline with age, and in some men this decline reaches a clinically significant threshold that genuinely warrants treatment. But most men experiencing the symptoms associated with "low T" have levels within the normal range. Understanding what is actually happening - and what actually helps - requires separating the physiology from the commercial noise.
Total testosterone peaks in the late teens to early twenties and begins a gradual decline from approximately age 30 to 40, at a rate of roughly 1 to 2 per cent per year. This sounds alarming until you do the arithmetic: a man who is 50 years old has, in the absence of other health conditions, likely experienced somewhere between 10 and 20 per cent of total decline from his personal peak. The wide normal range for testosterone - roughly 300 to 1000 ng/dL by most clinical guidelines - means that many men will reach their sixties with total testosterone still well within what is considered normal for any age.
The clinical picture is complicated by a distinction that most direct-to-consumer testosterone marketing ignores: the difference between total testosterone and free testosterone. Total testosterone measures all the hormone in the blood, including what is bound to proteins - particularly sex hormone-binding globulin (SHBG) and albumin. Only the unbound fraction, referred to as free testosterone, is biologically active. As men age, SHBG levels tend to rise. This means total testosterone can appear within the normal range while free testosterone - the portion actually available to tissues - is meaningfully lower than it once was. A full diagnostic picture requires measuring both, or calculating free testosterone from total and SHBG values.
The symptoms that are well-evidenced as consequences of genuinely low testosterone are more specific than the broad "fatigue and low motivation" that testosterone marketing tends to claim. Reduced sexual desire - libido - is the symptom most consistently associated with low testosterone in research. This is distinct from the ability to achieve an erection; desire and erectile function are partially separable systems. Loss of spontaneous and morning erections is also a relatively specific indicator. Loss of muscle mass and increased body fat, particularly around the abdomen, have meaningful associations with low testosterone at the population level.
Mood changes - specifically depression and reduced motivation - do have an evidence base in the context of genuinely low testosterone, though the effect is modest and confounded by the fact that depression itself suppresses testosterone. Fatigue and reduced energy are reported commonly but are among the least specific symptoms, since they are associated with dozens of other conditions that should be ruled out first.
What is notably not reliably caused by low testosterone: general life dissatisfaction, relationship difficulties, professional burnout, lack of ambition, or the normal psychological effects of ageing. These are real experiences that deserve attention on their own terms, but attributing them to low testosterone and pursuing hormonal treatment is unlikely to resolve them. The Endocrine Society's clinical practice guideline is explicit that testosterone therapy should not be offered for general wellbeing or anti-ageing purposes in men whose levels are not clinically low.
The minimum standard for diagnosis is two separate blood tests confirming low testosterone, both taken in the morning and in a fasted state. Testosterone follows a circadian rhythm, peaking in the early morning and declining through the day - an afternoon test can produce a result 20 to 30 per cent lower than a morning test in the same individual. A single test is not sufficient for diagnosis; guidelines require confirmation. The morning, fasting requirement is not logistical fastidiousness but clinical necessity.
In India, the landscape of who to see varies by city. Endocrinologists are the most appropriate specialists and are available in most major cities. Urologists frequently manage testosterone-related conditions and are more accessible in smaller cities. General physicians can initiate the diagnostic process but may lack the expertise to interpret the nuances of the free versus total distinction or to manage TRT ongoing. The direct-to-consumer testosterone testing market in India has expanded considerably, but quality varies - some services use suboptimal assay methods or do not include the free testosterone and SHBG measurements that a complete picture requires. If testing outside a hospital laboratory, verify that the assay method is electrochemiluminescence immunoassay (ECLIA) or equivalent, not older radioimmunoassay methods.
Before any discussion of testosterone replacement, the evidence is clear that several modifiable lifestyle factors have clinically meaningful effects on testosterone levels - and that addressing these should be the first step in any man experiencing symptoms consistent with low testosterone. These are not clichés dressed up as medicine. The effect sizes are real.
Sleep is perhaps the most underappreciated factor. Testosterone is secreted predominantly during sleep, with peak secretion occurring during REM sleep. A 2011 study in JAMA found that one week of sleep restriction to five hours per night reduced daytime testosterone levels by 10 to 15 per cent in healthy young men. Chronic poor sleep - extremely common in working-age Indian men - suppresses testosterone meaningfully and persistently. Prioritising sleep duration and quality is not peripheral advice but a direct intervention in hormone production.
Body weight matters for a specific biochemical reason. Adipose tissue - body fat - contains the enzyme aromatase, which converts testosterone into oestradiol, a form of oestrogen. Men with higher body fat therefore convert more testosterone, reducing circulating levels. Weight loss in overweight men reliably raises testosterone, and the effect can be substantial. Alcohol intake suppresses the hypothalamic-pituitary-gonadal axis at chronically elevated doses, reducing the signal that tells the testes to produce testosterone. Resistance training - weight training or bodyweight exercise against meaningful load - raises testosterone both acutely after each session and chronically over time, through mechanisms related to muscle mass and insulin sensitivity.
When two morning blood tests confirm clinically low testosterone and significant symptoms are present, testosterone replacement therapy (TRT) is an evidence-based treatment with genuine benefits. The forms available in India include intramuscular injections - administered every two to four weeks depending on the ester - topical gels applied daily, and transdermal patches. Each has practical trade-offs in terms of stability of blood levels, convenience, and cost. Injections produce more variability in levels (high shortly after injection, declining before the next); gels provide more stable levels but require care around skin contact transfer.
The critical caveat for any man who may wish to have children is that exogenous testosterone suppresses the body's own production through negative feedback on the hypothalamic-pituitary axis. This includes suppression of sperm production. TRT is not a contraceptive, but it meaningfully reduces sperm count and can cause infertility that may take many months to reverse after stopping. For younger men with low testosterone who are considering fertility, alternative approaches - most notably clomiphene citrate, a selective oestrogen receptor modulator that stimulates the pituitary to increase testosterone production - preserve fertility while addressing low testosterone. This is an important discussion to have explicitly with any prescribing physician.
The widely marketed category of "testosterone boosters" sold online and in supplement shops in India is largely without clinical evidence. Most contain zinc, vitamin D, fenugreek, or tribulus terrestris - none of which have demonstrated consistent, clinically meaningful effects on testosterone in men who are not deficient in a specific micronutrient. Ashwagandha (Withania somnifera) is the exception; a modest but genuine evidence base suggests it can reduce cortisol and produce small increases in testosterone, particularly in stressed men. The effect is real but modest, and ashwagandha is not a substitute for TRT in genuinely hypogonadal men.
Among the sexual health dimensions of testosterone, desire is the most sensitive. The relationship between testosterone and libido is well-established - men with clinically low testosterone consistently report reduced sexual desire, and testosterone replacement consistently improves it. The 2005 meta-analysis by Isidori and colleagues in the European Journal of Urology examined 17 randomised controlled trials and found significant improvements in sexual desire, erectile function, and sexual satisfaction in men receiving testosterone replacement versus placebo.
However, the relationship between testosterone and erectile function is more complex. Erections require adequate testosterone, but they also require healthy blood vessels, intact nerve function, and the absence of significant psychological interference. In men over 40, vascular health - blood pressure, endothelial function, the same factors that drive cardiovascular risk - is frequently the primary determinant of erectile quality. Many men presenting with both low testosterone and erectile dysfunction have underlying vascular disease that testosterone replacement alone will not resolve. The combination of low T and cardiovascular risk factors is extremely common in middle-aged Indian men, given the elevated rates of type 2 diabetes, hypertension, and metabolic syndrome in this population. Treating both - the hormonal and the vascular - is often necessary for a full response. A comprehensive evaluation that includes cardiovascular risk assessment alongside testosterone levels gives a far more actionable picture than testosterone alone.